You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Transient gadolinium leakage in natalizumab-treated multiple sclerosis

Authors

  • Sven Haller Department of Imaging and Medical Informatics, University Hospitals of Geneva and Faculty of Medicine of the University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Frederik Barkhof Department of Radiology & Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Mike P Wattjes Department of Radiology & Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Patrice H Lalive Department of Clinical Neurosciences, Division of Neurology, Unit of Neuroimmunology and Multiple Sclerosis, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland Department of Genetic and Laboratory Medicine, Division of Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sven Haller, Service neuro-diagnostique et neuro-interventionnel DISIM, University Hospitals of Geneva, Rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland; sven.haller{at}hcuge.ch
View Full Text

Citation

Haller S, Barkhof F, Wattjes MP, et al
Transient gadolinium leakage in natalizumab-treated multiple sclerosis
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:475-476.

Publication history

  • Received July 24, 2014
  • Revised August 29, 2014
  • Accepted August 30, 2014
  • First published September 22, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions